Subsequently other mutations causing aberrant JAK-STAT signaling in MPN have been reported to occur in patients with MPN who are negative for the JAK2V617F mutation,9, 10, 11 confirming that constitutive JAK-STAT signaling is the key pathway driving MPN phenotype.12 The gene discussed is SOAT1; the disease is myeloproliferative neoplasm.